Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-002185-21Phase 4Completed
Phase 4, open-label trial of ferric carboxymaltose and ferrous sulfate in anaemia (2 arms), sponsored by Nottingham University Hospitals NHS Trust (Research & Innovation). Primary endpoint: Rate of blood transfusion pre and intra-operatively. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-002185-21.